Physician profile
Mathew Thomas
NPI 1548436058
$22,672.93
in general payments reported to CMS, 2019-2025
14 companies · $19K in 2025
The $19K reported for 2025 was more than what 93% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.75 · 2021: $2,721 · 2022: $103 · 2023: $802 · 2024: $314 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,844 · Education: $5,500 · Travel and Lodging: $4,101 · Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,844.00 |
| Education | $5,500.00 |
| Travel and Lodging | $4,101.13 |
| Food and Beverage | $2,345.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,132.38 | 2021-2025 | |
| United Therapeutics Corporation | $9,100.33 | 2025 | |
| Medtronic, INC. | $1,604.36 | 2021-2023 | Linq II |
| Astrazeneca Pharmaceuticals Lp | $1,074.00 | 2021 | |
| Lexington Medical, INC. | $502.94 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Fujifilm Healthcare Americas Corporation | $239.28 | 2023-2024 | Fujifilm |
| Boston Scientific Corporation | $233.83 | 2022-2024 | |
| Depuy Synthes Sales INC. | $176.09 | 2025 | Matrixrib, Trumatch |
| Kerecis Limited | $143.30 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Atricure, INC. | $136.62 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| On Target Laboratories, INC | $130.17 | 2025 | Cytalux |
| Activ Surgical, INC. | $108.51 | 2023 | Activsight |
| Auris Health, INC. | $58.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $32.37 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.